Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

617 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Induction of heme oxygenase-1 before conditioning results in improved survival and reduced graft-versus-host disease after experimental allogeneic bone marrow transplantation.
Gerbitz A, Ewing P, Wilke A, Schubert T, Eissner G, Dietl B, Andreesen R, Cooke KR, Holler E. Gerbitz A, et al. Among authors: holler e. Biol Blood Marrow Transplant. 2004 Jul;10(7):461-72. doi: 10.1016/j.bbmt.2004.04.001. Biol Blood Marrow Transplant. 2004. PMID: 15205667 Free article.
Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination.
Holler E, Rogler G, Brenmoehl J, Hahn J, Herfarth H, Greinix H, Dickinson AM, Socié G, Wolff D, Fischer G, Jackson G, Rocha V, Steiner B, Eissner G, Marienhagen J, Schoelmerich J, Andreesen R. Holler E, et al. Blood. 2006 May 15;107(10):4189-93. doi: 10.1182/blood-2005-09-3741. Epub 2006 Jan 19. Blood. 2006. PMID: 16424393 Free article.
Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.
Schultz KR, Miklos DB, Fowler D, Cooke K, Shizuru J, Zorn E, Holler E, Ferrara J, Shulman H, Lee SJ, Martin P, Filipovich AH, Flowers ME, Weisdorf D, Couriel D, Lachenbruch PA, Mittleman B, Vogelsang GB, Pavletic SZ. Schultz KR, et al. Among authors: holler e. Biol Blood Marrow Transplant. 2006 Feb;12(2):126-37. doi: 10.1016/j.bbmt.2005.11.010. Biol Blood Marrow Transplant. 2006. PMID: 16443511 Free article.
Skin explant model of human graft-versus-host disease: prediction of clinical outcome and correlation with biological risk factors.
Wang XN, Collin M, Sviland L, Marshall S, Jackson G, Schulz U, Holler E, Karrer S, Greinix H, Elahi F, Hromadnikova I, Dickinson AM. Wang XN, et al. Among authors: holler e. Biol Blood Marrow Transplant. 2006 Feb;12(2):152-9. doi: 10.1016/j.bbmt.2005.09.018. Biol Blood Marrow Transplant. 2006. PMID: 16443513 Free article. Clinical Trial.
Isolation of CD4+CD25+ regulatory T cells for clinical trials.
Hoffmann P, Boeld TJ, Eder R, Albrecht J, Doser K, Piseshka B, Dada A, Niemand C, Assenmacher M, Orsó E, Andreesen R, Holler E, Edinger M. Hoffmann P, et al. Among authors: holler e. Biol Blood Marrow Transplant. 2006 Mar;12(3):267-74. doi: 10.1016/j.bbmt.2006.01.005. Biol Blood Marrow Transplant. 2006. PMID: 16503495 Free article.
617 results